loadpatents
name:-0.033074855804443
name:-0.03538990020752
name:-0.00041890144348145
McEver; Rodger P. Patent Filings

McEver; Rodger P.

Patent Applications and Registrations

Patent applications and USPTO patent grants for McEver; Rodger P..The latest application filed is for "cells treated by in vitro fucosylation and methods of production and use thereof".

Company Profile
0.34.27
  • McEver; Rodger P. - Oklahoma City OK
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Cells treated by in vitro fucosylation and methods of production and use thereof
Grant 10,799,538 - Xia , et al. October 13, 2
2020-10-13
Cells Treated by In Vitro Fucosylation and Methods of Production and Use Thereof
App 20180078583 - Xia; Lijun ;   et al.
2018-03-22
Methods of treating sickle cell disease with anti-P-selectin antibodies
Grant 9,556,266 - McEver , et al. January 31, 2
2017-01-31
Cells treated by in vitro fucosylation and methods of production and use thereof
Grant 9,511,095 - Xia , et al. December 6, 2
2016-12-06
Cells Treated by In Vitro Fucosylation and Methods of Production and Use Thereof
App 20160331785 - Xia; Lijun ;   et al.
2016-11-17
Anti-P Selectin Antibodies and Methods of Their Use and Identification
App 20160304612 - Alvarez; Richard ;   et al.
2016-10-20
Anti-P-selectin antibodies
Grant 9,068,001 - Rollins , et al. June 30, 2
2015-06-30
Methods of treating inflammatory or thrombotic conditions with anti-P-selectin antibodies
Grant 8,945,565 - Rollins , et al. February 3, 2
2015-02-03
Anti-P-Selectin Antibodies and Methods of Using The Same to Treat Inflammatory Diseases
App 20140072551 - MCEVER; Rodger P. ;   et al.
2014-03-13
Stem cells treated by in vitro fucosylation and methods of use
Grant 8,633,021 - Xia , et al. January 21, 2
2014-01-21
Cells Treated By In Vitro Fucosylation And Methods Of Production And Use Thereof
App 20130251688 - Xia; Lijun ;   et al.
2013-09-26
Anti-P-selectin antibodies and methods of using the same to treat inflammatory diseases
Grant 8,377,440 - McEver , et al. February 19, 2
2013-02-19
Stem cells treated by in vitro fucosylation and methods of use
Grant 8,084,255 - Xia , et al. December 27, 2
2011-12-27
Anti-p-selectin Antibodies And Methods Of Their Use And Identification
App 20110293617 - Rollins; Scott ;   et al.
2011-12-01
Anti-p-selectin Antibodies And Methods Of Their Use And Identification
App 20110287017 - Rollins; Scott ;   et al.
2011-11-24
Anti-p-selectin Antibodies And Methods Of Using The Same To Treat Inflammatory Diseases
App 20110243926 - McEver; Rodger P. ;   et al.
2011-10-06
Anti-p-selectin Antibodies And Methods Of Their Use And Identification
App 20110212096 - Rollins; Scott ;   et al.
2011-09-01
Stem Cells Treated By In Vitro Fucosylation And Methods Of Use
App 20110097308 - Xia; Lijun ;   et al.
2011-04-28
Hematopoietic stem cells treated by in vitro fucosylation and methods of use
Grant 7,776,591 - Xia , et al. August 17, 2
2010-08-17
Stem Cells Treated By In Vitro Fucosylation And Methods Of Use
App 20100150883 - Xia; Lijun ;   et al.
2010-06-17
Glycosulfopeptide inhibitors of leukocyte rolling and methods of use thereof
Grant 7,470,776 - Cummings , et al. December 30, 2
2008-12-30
Hematopoietic stem cells treated by in vitro fucosylation and methods of use
Grant 7,332,334 - Xia , et al. February 19, 2
2008-02-19
Glycosulfopeptide inhibitors of leukocyte rolling and methods of use thereof
App 20070167356 - Cummings; Richard D. ;   et al.
2007-07-19
Synthetic glycosulfopeptides and methods of synthesis thereof
Grant 7,223,845 - Cummings , et al. May 29, 2
2007-05-29
Glycosulfopeptide inhibitors of leukocyte rolling and methods of use thereof
Grant 7,189,828 - Cummings , et al. March 13, 2
2007-03-13
Hematopoietic stem cells treated by in vitro fucosylation and methods of use
App 20060228340 - Xia; Lijun ;   et al.
2006-10-12
Glycosulfopeptide inhibitors of leukocyte rolling and methods of use thereof
App 20060024779 - Cummings; Richard D. ;   et al.
2006-02-02
Synthetic glycosulfopeptides and methods of synthesis thereof
App 20050282770 - Cummings, Richard D. ;   et al.
2005-12-22
Hematopoietic stem cells treated by in vitro fucosylation and methods of use
App 20040209357 - Xia, Lijun ;   et al.
2004-10-21
Methods of detecting disorders involving defective p-selectin glycoprotein ligand or defective p-selectin
App 20040132105 - Cummings, Richard D. ;   et al.
2004-07-08
Methods of treatment using antibodies to P-selectin glycoprotein ligand
Grant 6,667,036 - Cummings , et al. December 23, 2
2003-12-23
Peptide inhibitors of inflammation mediated by selectins
App 20030144211 - Heavner, George A. ;   et al.
2003-07-31
Synthetic glycosulfopeptides and methods of synthesis thereof
App 20030144183 - Cummings, Richard D. ;   et al.
2003-07-31
Glycosulfopeptide inhibitors of leukocyte rolling and methods of use thereof
App 20030143662 - Cummings, Richard D. ;   et al.
2003-07-31
Glycosulfopeptide inhibitors of leukocyte rolling and methods of use thereof
App 20030130174 - Cummings, Richard D. ;   et al.
2003-07-10
Synthetic glycosulfopeptides and methods of synthesis thereof
Grant 6,569,998 - Cummings , et al. May 27, 2
2003-05-27
Methods of treatment using antibodies to P-selectin glycoprotein ligand
App 20030072755 - Cummings, Richard D. ;   et al.
2003-04-17
Peptide inhibitors of inflammation mediated by selectins
Grant 6,528,487 - Heavner , et al. March 4, 2
2003-03-04
Method for inhibiting reperfusion injury using antibodies to P-selectin glycoprotein ligand
Grant 6,506,382 - Cummings , et al. January 14, 2
2003-01-14
Method for Inhibiting reperfusion injury using antibodies to P-selectin glycoprotein ligand
App 20020122796 - Cummings, Richard D. ;   et al.
2002-09-05
Synthetic glycosulfopeptides and methods of synthesis thereof
App 20020042102 - Cummings, Richard D. ;   et al.
2002-04-11
Synthetic glycosulfopeptides and methods of synthesis thereof
App 20020026033 - Cummings, Richard D. ;   et al.
2002-02-28
Method for inhibiting an inflammatory response using antibodies to P-selectin glycoprotein ligand
Grant 6,309,639 - Cummings , et al. October 30, 2
2001-10-30
Antibodies to P-selectin glycoprotein ligand
Grant 6,177,547 - Cummings , et al. January 23, 2
2001-01-23
O-glycan inhibitors of selectin mediated inflammation derived from PSGL-1
Grant 6,124,267 - McEver , et al. September 26, 2
2000-09-26
Peptide inhibitors of inflammation mediated by selectins
Grant 6,111,065 - Heavner , et al. August 29, 2
2000-08-29
Ligand or GMP-140 selectin and methods of use thereof
Grant 5,929,036 - McEver July 27, 1
1999-07-27
Glycoprotein ligand for P-selectin and methods of use thereof
Grant 5,880,091 - Cummings , et al. March 9, 1
1999-03-09
P-selectin glycoprotein ligand blocking antibodies
Grant 5,852,175 - Cummings , et al. December 22, 1
1998-12-22
Soluble form of GMP-140
Grant 5,767,241 - McEver June 16, 1
1998-06-16
Expression control sequences of the P-selectin gene
Grant 5,605,821 - McEver , et al. February 25, 1
1997-02-25
Glycoprotein ligand for P-selectin and methods of use thereof
Grant 5,464,778 - Cummings , et al. November 7, 1
1995-11-07
Modulation of inflammatory responses by administration of GMP-140 or antibody to GMP-140
Grant 5,378,464 - McEver January 3, 1
1995-01-03
Functionally active selectin-derived peptides
Grant 5,198,424 - McEver March 30, 1
1993-03-30
Methods for imaging atherosclerotic plaque
Grant 5,026,537 - Daddona , et al. June 25, 1
1991-06-25
Company Registrations

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed